We are live on ! Find out more
USNA icon

Usana Health Sciences

144 hedge funds and large institutions have $621M invested in Usana Health Sciences in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 42 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 42

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

1% less funds holding

Funds holding: 145144 (-1)

0.91% less ownership

Funds ownership: 45.46%44.55% (-0.91%)

2% less call options, than puts

Call options by funds: $4.68M | Put options by funds: $4.75M

13% less capital invested

Capital invested by funds: $714M → $621M (-$93.2M)

Holders
144
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
3.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
52
Reduced
42
Closed
23
Calls
$4.68M
Puts
$4.75M
Net Calls
-$76K
Net Calls Change
-$712K
Name Holding Trade Value Shares
Change
Change in
Stake
JG
76
Jefferies Group
New York
$489K +$501K +8,475 New
AA
77
ALPS Advisors
Colorado
$470K -$12.3K -208 -2%
MLICM
78
Metropolitan Life Insurance Company (MetLife)
New York
$466K
DekaBank Deutsche Girozentrale
79
DekaBank Deutsche Girozentrale
Germany
$454K +$161K +2,732 +52%
AIG
80
American International Group
New York
$449K +$34.4K +582 +8%
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
$448K +$165K +2,791 +56%
Acadian Asset Management
82
Acadian Asset Management
Massachusetts
$387K -$723K -12,230 -65%
Barclays
83
Barclays
United Kingdom
$383K -$1.37M -23,195 -78%
Cerity Partners
84
Cerity Partners
New York
$373K +$35.9K +607 +10%
NFA
85
Nationwide Fund Advisors
Ohio
$369K -$11.2K -190 -3%
SAM
86
Shell Asset Management
Netherlands
$366K -$11.8K -200 -3%
Connor, Clark & Lunn Investment Management (CC&L)
87
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$364K +$372K +6,300 New
MC
88
Menta Capital
California
$350K -$1.26M -21,320 -78%
LA
89
Lucus Advisors
New York
$348K +$357K +6,038 New
VOYA Investment Management
90
VOYA Investment Management
Georgia
$330K
EMG
91
Ellington Management Group
Connecticut
$329K +$337K +5,700 New
Citigroup
92
Citigroup
New York
$324K +$117K +1,981 +55%
B
93
Barings
North Carolina
$323K
SCA
94
Secor Capital Advisors
New York
$319K +$327K +5,531 New
Balyasny Asset Management
95
Balyasny Asset Management
Illinois
$303K +$310K +5,250 New
SCM
96
Symons Capital Management
Pennsylvania
$299K -$12.4K -210 -4%
HI
97
HBK Investments
Texas
$294K -$1.27M -21,500 -81%
Capstone Investment Advisors
98
Capstone Investment Advisors
New York
$294K +$301K +5,100 New
TCOV
99
Trust Company of Vermont
Vermont
$272K +$230K +3,900 +483%
Legal & General Group
100
Legal & General Group
United Kingdom
$248K +$14.7K +249 +6%

USNA Hedge Fund Activity: Q3 2017 in Review

144 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2017, worth a combined $621M — down 13% from $714M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 23 closed out — a net gain of 1 holder — while 52 added to existing stakes and 42 trimmed.

The largest buyer was Norges Bank, adding an estimated $10.1M. The largest seller was Two Sigma Investments, cutting an estimated $7.68M.

  • 144 institutional investors held Usana Health Sciences (USNA) as of Q3 2017, down from 145 in Q2 2017.
  • Funds reported $621M of Usana Health Sciences stock for Q3 2017, down 13% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q3 2017 and 23 closed out, a net change of +1 holder.
  • The largest Usana Health Sciences buyer in Q3 2017 was Norges Bank, an estimated $10.1M added.
  • The largest Usana Health Sciences seller in Q3 2017 was Two Sigma Investments, an estimated $7.68M sold.

Based on aggregated 13F filings for Q3 2017.